Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases.

A. Tripathi*, A. M. Ditto, L. C. Grammer, P. A. Greenberger, K. G. McGrath, C. R. Zeiss, R. Patterson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

95 Scopus citations


Stevens-Johnson syndrome (SJS) is a severe cutaneous eruption that can be a life-threatening emergency. Previously, we have reported our favorable experience in treating 54 patients with SJS with systemic corticosteroids. We continued our prospective analysis of consecutive patients with SJS treated with corticosteroids. Possible etiologic factors and clinical outcomes of the patients are described. All 13 patients improved with initiation of systemic corticosteroid therapy. There was no mortality or permanent sequelae attributable to SJS. Drugs were the offending agents in all 13 cases. There was one death unrelated to SJS. In conclusion, prompt treatment with systemic corticosteroids reduces morbidity and improves outcome of SJS patients. This analysis extends our series to 67 consecutive patients with SJS who were treated with corticosteroids and had a favorable outcome.

Original languageEnglish (US)
Pages (from-to)101-105
Number of pages5
JournalAllergy and asthma proceedings : the official journal of regional and state allergy societies
Issue number2
StatePublished - 2000

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Immunology and Allergy


Dive into the research topics of 'Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases.'. Together they form a unique fingerprint.

Cite this